Influence of cartilage extracellular matrix molecules on cell phenotype and neocartilage formation

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 264-274

  Grogan, Shawn P ^a,b   Chen, Xian ^a   Sovani, Sujata ^a   Taniguchi, Noboru ^b   Colwell, Clifford W ^a   Lotz, Martin K ^a,b   D'Lima, Darryl D ^a,b  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARTILAGE; CELLS; COLLAGEN; CYTOLOGY; GENE EXPRESSION; HISTOLOGY; HYALURONIC ACID; MOLECULES; PELLETIZING; POLYMERASE CHAIN REACTION; RNA; THREE DIMENSIONAL; TISSUE;

CARTILAGE EXTRACELLULAR MATRIXES; CARTILAGE FORMATION; CARTILAGE REGENERATION; HUMAN ARTICULAR CHONDROCYTES; LOAD-BEARING TISSUES; MESSENGER RNAS (MRNA); REAL-TIME POLYMERASE CHAIN REACTION; THREE-DIMENSIONAL (3D) ENVIRONMENTS;

GLYCOPROTEINS;

AGGRECAN; ALGINIC ACID; BIGLYCAN; CARTILAGE INTERMEDIATE LAYER PROTEIN; CLUSTERIN; COLLAGEN TYPE 10ALPHA 1; COLLAGEN TYPE 1ALPHA 1; COLLAGEN TYPE 2; COLLAGEN TYPE 2ALPHA 1; DECORIN; HYALURONIC ACID; MESSENGER RNA; OSTEOPONTIN; PROTEOGLYCAN; PROTEOGLYCAN 4; SCLEROPROTEIN; TENASCIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ARTICULAR CARTILAGE; BONE REGENERATION; CARTILAGE CELL; CARTILAGINOUS TISSUE; CELL COUNT; CELL ENCAPSULATION; CELL EXPANSION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOGENESIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MONOLAYER CULTURE; NEOCARTILAGE FORMATION; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGGRECANS; ALGINATES; CARTILAGE, ARTICULAR; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MALE; ORGAN SPECIFICITY; PHENOTYPE; PROTEOGLYCANS; RNA, MESSENGER;

EID: 84891499501     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0618     Document Type: Article

References (76)

1. Grogan, S.P., Miyaki, S., Asahara, H., D'Lima, D.D., and Lotz, M.K. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 11, R85, 2009.
2. Waldman, S.D., Grynpas, M.D., Pilliar, R.M., and Kandel, R.A. The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage. J Orthop Res 21, 132, 2003.
3. Flannery, C.R., Hughes, C.E., Schumacher, B.L., Tudor, D., Aydelotte, M.B., Kuettner, K.E., et al. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun 254, 535, 1999.
4. Schumacher, B.L., Block, J.A., Schmid, T.M., Aydelotte, M.B., and Kuettner, K.E. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 311, 144, 1994.
5. Schumacher, B.L., Hughes, C.E., Kuettner, K.E., Caterson, B., and Aydelotte, M.B. Immunodetection and partial cDNA sequence of the proteoglycan, superficial zone protein, synthesized by cells lining synovial joints. J Orthop Res 17, 110, 1999.
6. Ikegawa, S., Sano, M., Koshizuka, Y., and Nakamura, Y. Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes. Cytogenet Cell Genet 90, 291, 2000.
7. Schmidt, T.A., Schumacher, B.L., Klein, T.J., Voegtline, M.S., and Sah, R.L. Synthesis of proteoglycan 4 by chondrocyte subpopulations in cartilage explants, monolayer cultures, and resurfaced cartilage cultures. Arthritis Rheum 50, 2849, 2004.
8. Khan, I.M., Salter, D.M., Bayliss, M.T., Thomson, B.M., and Archer, C.W. Expression of clusterin in the superficial zone of bovine articular cartilage. Arthritis Rheum 44, 1795, 2001.
9. Darling, E.M., Hu, J.C., and Athanasiou, K.A. Zonal and topographical differences in articular cartilage gene expression. J Orthop Res 22, 1182, 2004.
10. Hidaka, C., Cheng, C., Alexandre, D., Bhargava, M., and Torzilli, P.A. Maturational differences in superficial and deep zone articular chondrocytes. Cell Tissue Res 323, 127, 2006.
11. Aydelotte, M.B., Greenhill, R.R., and Kuettner, K.E. Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect Tissue Res 18, 223, 1988.
12. Aydelotte, M.B., and Kuettner, K.E. Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect Tissue Res 18, 205, 1988.
13. Siczkowski, M., and Watt, F.M. Subpopulations of chondrocytes from different zones of pig articular cartilage. Isolation, growth and proteoglycan synthesis in culture. J Cell Sci 97 (Pt 2), 349, 1990.
14. Zanetti, M., Ratcliffe, A., and Watt, F.M. Two subpopulations of differentiated chondrocytes identified with a monoclonal antibody to keratan sulfate. J Cell Biol 101, 53, 1985.
15. Miosge, N., Flachsbart, K., Goetz, W., Schultz, W., Kresse, H., and Herken, R. Light and electron microscopical immunohistochemical localization of the small proteoglycan core proteins decorin and biglycan in human knee joint cartilage. Histochem J 26, 939, 1994.
16. Poole, A.R., Rosenberg, L.C., Reiner, A., Ionescu, M., Bogoch, E., and Roughley, P.J. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res 14, 681, 1996.
17. Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 37, 138, 2005.
18. Pelletier, J.P., Jovanovic, D.V., Lascau-Coman, V., Fernandes, J.C., Manning, P.T., Connor, J.R., et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 43, 1290, 2000.
19. Roughley, P.J. The structure and function of cartilage proteoglycans. Eur Cell Mater 12, 92, 2006.
20. Midwood, K.S., and Orend, G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3, 287, 2009.
21. Nakoshi, Y., Hasegawa, M., Akeda, K., Iino, T., Sudo, A., Yoshida, T., et al. Distribution and role of tenascin-C in human osteoarthritic cartilage. J Orthop Sci 15, 666, 2010.
22. Bayliss, M.T., Venn, M., Maroudas, A., and Ali, S.Y. Structure of proteoglycans from different layers of human articular cartilage. Biochem J 209, 387, 1983.
23. Asari, A., Miyauchi, S., Kuriyama, S., Machida, A., Kohno, K., and Uchiyama, Y. Localization of hyaluronic acid in human articular cartilage. J Histochem Cytochem 42, 513, 1994.
24. Buschmann, M.D., Maurer, A.M., Berger, E., Perumbuli, P., and Hunziker, E.B. Ruthenium hexaammine trichloride chemography for aggrecan mapping in cartilage is a sensitive indicator of matrix degradation. J Histochem Cytochem 48, 81, 2000.
25. Franzen, A., Inerot, S., Hejderup, S.O., and Heinegard, D. Variations in the composition of bovine hip articular cartilage with distance from the articular surface. Biochem J 195, 535, 1981.
26. Maroudas, A., Muir, H., and Wingham, J. The correlation of fixed negative charge with glycosaminoglycan content of human articular cartilage. Biochim Biophys Acta 177, 492, 1969.
27. Ratcliffe, A., Fryer, P.R., and Hardingham, T.E. The distribution of aggregating proteoglycans in articular cartilage: comparison of quantitative immunoelectron microscopy with radioimmunoassay and biochemical analysis. J Histochem Cytochem 32, 193, 1984.
28. Wong, M., Wuethrich, P., Eggli, P., and Hunziker, E. Zonespecific cell biosynthetic activity in mature bovine articular cartilage: a new method using confocal microscopic stereology and quantitative autoradiography. J Orthop Res 14, 424, 1996.
29. Dudhia, J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 62, 2241, 2005.
30. Knudson, C.B. Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. Birth Defects Res C Embryo Today 69, 174, 2003.
31. Kempson, G.E. Relationship between the tensile properties of articular cartilage from the human knee and age. Ann Rheum Dis 41, 508, 1982.
32. Lorenzo, P., Bayliss, M.T., and Heinegard, D. A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 273, 23463, 1998.
33. Bernardo, B.C., Belluoccio, D., Rowley, L., Little, C.B., Hansen, U., and Bateman, J.F. Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis. J Biol Chem 286, 37758, 2011.
34. Venn, M.F. Variation of chemical composition with age in human femoral head cartilage. Ann Rheum Dis 37, 168, 1978.
35. Jacoby, R.K., and Jayson, M.I. Proceedings: adult human articular cartilage in organ culture. Synthesis of glycosaminoglycan, effect of hyperoxia, and zonal variation of matrix synthesis. Ann Rheum Dis 34, 468, 1975.
36. Mitrovic, D.R., and Darmon, N. Characterization of proteoglycans synthesized by different layers of adult human femoral head cartilage. Osteoarthritis Cartilage 2, 119, 1994.
37. Muir, H., Bullough, P., and Maroudas, A. The distribution of collagen in human articular cartilage with some of its physiological implications. J Bone Joint Surg Br 52, 554, 1970.
38. Pullig, O., Weseloh, G., Ronneberger, D., Kakonen, S., and Swoboda, B. Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 67, 230, 2000.
39. Schnapper, A., and Meyer, W. Osteopontin distribution in the canine skeleton during growth and structural maturation. Cells Tissues Organs 178, 158, 2004.
40. Matsui, Y., Iwasaki, N., Kon, S., Takahashi, D., Morimoto, J., Denhardt, D.T., et al. Accelerated development of agingassociated and instability-induced osteoarthritis in osteopontin- deficient mice. Arthritis Rheum 60, 2362, 2009.
41. Akmal, M., Singh, A., Anand, A., Kesani, A., Aslam, N., Goodship, A., et al. The effects of hyaluronic acid on articular chondrocytes. J Bone Joint Surg Br 87, 1143, 2005.
42. Chung, C., Beecham, M., Mauck, R.L., and Burdick, J.A. The influence of degradation characteristics of hyaluronic acid hydrogels on in vitro neocartilage formation by mesenchymal stem cells. Biomaterials 30, 4287, 2009.
43. Chung, C., and Burdick, J.A. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng Part A 15, 243, 2009.
44. Park, S.H., Cui, J.H., Park, S.R., and Min, B.H. Potential of fortified fibrin/hyaluronic acid composite gel as a cell delivery vehicle for chondrocytes. Artif Organs 33, 439, 2009.
45. Shin, H., Jo, S., and Mikos, A.G. Biomimetic materials for tissue engineering. Biomaterials 24, 4353, 2003.
46. Veilleux, N.H., Yannas, I.V., and Spector, M. Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen- glycosaminoglycan matrices in vitro. Tissue Eng 10, 119, 2004.
47. Barbero, A., Grogan, S.P., Mainil-Varlet, P., and Martin, I. Expansion on specific substrates regulates the phenotype and differentiation capacity of human articular chondrocytes. J Cell Biochem 98, 1140, 2006.
48. Gustafsson, E., Aszodi, A., Ortega, N., Hunziker, E.B., Denker, H.W., Werb, Z., et al. Role of collagen type II and perlecan in skeletal development. Ann N Y Acad Sci 995, 140, 2003.
49. Yang, K.G., Saris, D.B., Geuze, R.E., Helm, Y.J., Rijen, M.H., Verbout, A.J., et al. Impact of expansion and redifferentiation conditions on chondrogenic capacity of cultured chondrocytes. Tissue Eng 12, 2435, 2006.
50. Yang, W.D., Gomes, R.R., Jr., Alicknavitch, M., Farach- Carson, M.C., and Carson, D.D. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng 11, 76, 2005.
51. Grogan, S.P., Sovani, S., Pauli, C., Chen, J., Hartmann, A., Colwell, C.W., Jr., et al. Effects of perfusion and dynamic loading on human neocartilage formation in alginate hydrogels. Tissue Eng Part A 18, 1784, 2012.
52. Martin, I., Jakob, M., Schafer, D., Dick, W., Spagnoli, G., and Heberer, M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9, 112, 2001.
53. Grogan, S.P., Aklin, B., Frenz, M., Brunner, T., Schaffner, T., and Mainil-Varlet, P. In vitro model for the study of necrosis and apoptosis in native cartilage. J Pathol 198, 5, 2002.
54. Taniguchi, N., Carames, B., Ronfani, L., Ulmer, U., Komiya, S., Bianchi, M.E., et al. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 106, 1181, 2009.
55. Barbero, A., Ploegert, S., Heberer, M., and Martin, I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 48, 1315, 2003.
56. Chen, C.W., Tsai, Y.H., Deng, W.P., Shih, S.N., Fang, C.L., Burch, J.G., et al. Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res 23, 446, 2005.
57. Lu, Z., Doulabi, B.Z., Huang, C., Bank, R.A., and Helder, M.N. Collagen type II enhances chondrogenesis in adipose tissue-derived stem cells by affecting cell shape. Tissue Eng Part A 16, 81, 2010.
58. Mackie, E.J., and Murphy, L.I. The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc Res Tech 43, 102, 1998.
59. Murphy, L.I., Fischer, D., Chiquet-Ehrismann, R., and Mackie, E.J. Tenascin-C induced stimulation of chondrogenesis is dependent on the presence of the C-terminal fibrinogen-like globular domain. FEBS Lett 480, 189, 2000.
60. Midwood, K.S., and Schwarzbauer, J.E. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rhomediated signaling pathways. Mol Biol Cell 13, 3601, 2002.
61. Wenk, M.B., Midwood, K.S., and Schwarzbauer, J.E. Tenascin- C suppresses Rho activation. J Cell Biol 150, 913, 2000.
62. Mathieu, P.S., and Loboa, E.G. Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Eng Part B Rev 18, 436, 2012.
63. Salinas, C.N., and Anseth, K.S. Decorin moieties tethered into PEG networks induce chondrogenesis of human mesenchymal stem cells. J Biomed Mater Res A 90, 456, 2009.
64. Chung, C., Mesa, J., Randolph, M.A., Yaremchuk, M., and Burdick, J.A. Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks. J Biomed Mater Res A 77, 518, 2006.
65. Responte, D.J., Natoli, R.M., and Athanasiou, K.A. Identification of potential biophysical and molecular signalling mechanisms underlying hyaluronic acid enhancement of cartilage formation. J R Soc Interface 9, 3564, 2012.
66. Ryan, C., Coleman, C.M., Murphy, M., and Barry, F. hMSC interaction with environmental hyaluronan influences chondrogenic potential. Trans 56th Orthop Res Soc 35, Poster No. 761, 2010.
67. Sugahara, K.N., Murai, T., Nishinakamura, H., Kawashima, H., Saya, H., and Miyasaka, M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278, 32259, 2003.
68. Maleski, M.P., and Knudson, C.B. Hyaluronan-mediated aggregation of limb bud mesenchyme and mesenchymal condensation during chondrogenesis. Exp Cell Res 225, 55, 1996.
69. Wu, S.C., Chen, C.H., Chang, J.K., Fu, Y.C., Wang, C.K., Eswaramoorthy, R., et al. Hyaluronan initiates chondrogenesis mainly via CD44 in human adipose derived stem cells. J Appl Physiol 114, 1610, 2013.
70. Diaz-Romero, J., Gaillard, J.P., Grogan, S.P., Nesic, D., Trub, T., and Mainil-Varlet, P. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 202, 731, 2005.
71. Grogan, S.P., Barbero, A., Diaz-Romero, J., Cleton-Jansen, A.M., Soeder, S., Whiteside, R., et al. Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum 56, 586, 2007.
72. Roberts, S., McCall, I.W., Darby, A.J., Menage, J., Evans, H., Harrison, P.E., et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther 5, R60, 2003.
73. Singelyn, J.M., and Christman, K.L. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res 3, 478, 2010.
74. Stapleton, T.W., Ingram, J., Fisher, J., and Ingham, E. Investigation of the regenerative capacity of an acellular porcine medial meniscus for tissue engineering applications. Tissue Eng Part A 17, 231, 2011.
75. Darling, E.M., and Athanasiou, K.A. Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng 11, 395, 2005.
76. Schrobback, K., Malda, J., Crawford, R.W., Upton, Z., Leavesley, D.I., and Klein, T.J. Effects of oxygen on zonal marker expression in human articular chondrocytes. Tissue Eng Part A 18, 920, 2012.